0 CHECKOUT

Puerto Rico Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3454176
  • November 2015
  • Region: Puerto Rico
  • 91 pages
  • Business Monitor International
1 of 3

While the forecast for Puerto Rico has remained at a stable trajectory, the US territory is facing an uncertain future, caused by US congressional healthcare decisions that much of the island's population feel will lead to widespread economic harm. In addition to this, Puerto Rico's reputation as being a hub of pharmaceutical and biotech manufacturing is in jeopardy due to changes to US laws that protected multinational manufacturing companies based there from US taxes.

Headline Expenditure Projections
- Pharmaceuticals: USD3.02bn in 2014 to USD3.03bn in 2015; 0.28%. Forecast on par with Q415.

- Healthcare: USD7.79bn in 2014 to USD8.07bn in 2015; +3.7%. Forecast unchanged since Q315.

Note: Product cover images may vary from those shown
2 of 3

Table: Headline Pharmaceuticals & Healthcare Forecasts (Puerto Rico 2013-2019)
Table: Headline Pharmaceuticals & Healthcare Forecasts (Puerto Rico 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Puerto Rico 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Puerto Rico 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Puerto Rico 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Puerto Rico 2013-2019)

Pharmaceuticals & Healthcare Risk/Reward Index

Americas Risk/Reward Index

Puerto Rico Risk/Reward Index

Rewards

Risks

Regulatory Review

Pricing And Reimbursement

Tax Incentives
Table: Incentives, Benefits And Discounts For Pharmaceutical Manufacturers

Trade Accords

Market Overview

Epidemiology

Healthcare Sector

Effects Of US Healthcare Reform

Healthcare Financing

Healthcare Provision

Medical Tourism

Research & Development

Biotechnology

Clinical Trials

Competitive Landscape

Pharmaceutical Industry
Table: Major International Drugmakers In Puerto Rico

Pharmaceutical Production

Plant Expansions
Table: Puerto Rico - Multinationals' Operations

Plant Closures

Company Developments
Table: Multinational Company Activity

Pharmaceutical Distribution

Pharmaceutical Retail

Company Profile

Abbott Laboratories

Eli Lilly

GlaxoSmithKline

Merck

Novartis

Sanofi

Demographic Forecast
Table: Population Headline Indicators (Puerto Rico 1990-2025)
Table: Key Population Ratios (Puerto Rico 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Puerto Rico 1990-2025)
Table: Population By Age Group (Puerto Rico 1990-2025)
Table: Population By Age Group % (Puerto Rico 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.